Cognitive decline in early Parkinson's disease

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 605-608

  Kandiah, Nagaendran ^a   Narasimhalu, Kaavya ^b   Lau, Puay Ngoh ^a   Seah, Soo Hoon ^a,b   Au, Wing Lok ^a   Tan, Louis C S ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cognition; Depression; Education; Mini mental state examination; Parkinson's disease

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; CHINESE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATION; ETHNICITY; FEMALE; HALLUCINATION; HUMAN; IDIOPATHIC DISEASE; INDIAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; AGED; ANALYSIS OF VARIANCE; EDUCATIONAL STATUS; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MENTAL HEALTH; MIDDLE AGED; MORTALITY; NEUROPSYCHOLOGICAL TEST; STATISTICAL MODEL;

AGED; ANALYSIS OF VARIANCE; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 67651177636     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22384     Document Type: Article

References (23)

1. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y. A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 1983;288:213-218.
2. Hilker R, Thomas AV, Klein JC, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 2005;65:1716-1722.
3. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:67-73.
4. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
5. Muslimovic D, Schmand B, Speelman JD, de Haan RJ. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc 2007;13:920-932
6. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, KraghSørensen P. Risk of dementia in Parkinson's disease: a community- based, prospective study. Neurology 2001;56:730-736.
7. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
8. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
9. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
10. de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 2005;62:1265-1269.
11. Glatt SL, Hubble JP, Lyons K, et al. Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology 1996;15:20-25.
12. Locascio JJ, Corkin S, Growdon JH. Relation between clinical characteristics of Parkinson's disease and cognitive decline. J Clin Exp Neuropsychol 2003;25:94-109.
13. Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004;61:1906-1911.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease [Review]. Arch Neurol 1999;56:33-39.
15. Sahadevan S, Tan NJ, Tan TC, Tan S. Cognitive testing of elderly Chinese from selected community clubs in Singapore. Ann Acad Med Singapore 1997;26:271-277.
16. Sahadevan S, Lim PP, Tan NJ, Chan SP. Diagnostic performance of two mental status tests in the older Chinese: influence of education and age on cut-off values. Int J Geriatr Psychiatry 2000;15:234-241.
17. Clark CM, Sheppard L, Fillenbaum GG, et al. Variability in annual mini-mental state examination score in patients with probable Alzheimer disease: a clinical perspective of data from the consortium to establish a registry for Alzheimer's Disease. Arch Neurol 1999;56:857-862.
18. Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB, Jr. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int J Geriatr Psychiatry 2003; 18:1115-1120.
19. Braak H, Rüb U, Del Tredici K. Cognitive decline correlates with neuropathological stage in Parkinson's disease. J Neurol Sci 2006;248:255-258.
20. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-382.
21. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. Cognitive functions in major depression and Parkinson disease. Arch Neurol 1997;54:982-986.
22. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community- based study. Ann Neurol 2005;58:773-776.
23. Levy G, Schupf N, Tang MX, et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002;51:722-729.